The Peptide Boom Is Getting Out of Hand The Atlantic FDA to weigh easing limits on unproven peptides promoted by RFK Jr. BPC 157: Experimental Peptide Creates Risk for Athletes FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,